BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36334976)

  • 1. Pulse Sequence Dependence of a Simple and Interpretable Deep Learning Method for Detection of Clinically Significant Prostate Cancer Using Multiparametric MRI.
    Kim H; Margolis DJA; Nagar H; Sabuncu MR
    Acad Radiol; 2023 May; 30(5):966-970. PubMed ID: 36334976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
    Xu L; Zhang G; Shi B; Liu Y; Zou T; Yan W; Xiao Y; Xue H; Feng F; Lei J; Jin Z; Sun H
    Cancer Imaging; 2019 Dec; 19(1):90. PubMed ID: 31864408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A deep dive into understanding tumor foci classification using multiparametric MRI based on convolutional neural network.
    Zong W; Lee JK; Liu C; Carver EN; Feldman AM; Janic B; Elshaikh MA; Pantelic MV; Hearshen D; Chetty IJ; Movsas B; Wen N
    Med Phys; 2020 Sep; 47(9):4077-4086. PubMed ID: 32449176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semi-automatic classification of prostate cancer on multi-parametric MR imaging using a multi-channel 3D convolutional neural network.
    Aldoj N; Lukas S; Dewey M; Penzkofer T
    Eur Radiol; 2020 Feb; 30(2):1243-1253. PubMed ID: 31468158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice.
    Zawaideh JP; Sala E; Shaida N; Koo B; Warren AY; Carmisciano L; Saeb-Parsy K; Gnanapragasam VJ; Kastner C; Barrett T
    Eur Radiol; 2020 Jul; 30(7):4039-4049. PubMed ID: 32166495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dynamic-static combination model based on radiomics features for prostate cancer using multiparametric MRI.
    Li S; Zheng T; Fan Z; Qu H; Wang J; Bi J; Lv Q; Zhang G; Cui X; Zhao Y
    Phys Med Biol; 2022 Dec; 68(1):. PubMed ID: 36541844
    [No Abstract]   [Full Text] [Related]  

  • 7. Prospective analysis of clinically significant prostate cancer detection with [
    Bodar YJL; Zwezerijnen BGJC; van der Voorn PJ; Jansen BHE; Smit RS; Kol SQ; Meijer D; de Bie K; Yaqub M; Windhorst BAD; Hendrikse HNH; Vis AN; Oprea-Lager DE
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1731-1742. PubMed ID: 34725727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autosegmentation of Prostate Zones and Cancer Regions from Biparametric Magnetic Resonance Images by Using Deep-Learning-Based Neural Networks.
    Lai CC; Wang HK; Wang FN; Peng YC; Lin TP; Peng HH; Shen SH
    Sensors (Basel); 2021 Apr; 21(8):. PubMed ID: 33921451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using decision curve analysis to benchmark performance of a magnetic resonance imaging-based deep learning model for prostate cancer risk assessment.
    Deniffel D; Abraham N; Namdar K; Dong X; Salinas E; Milot L; Khalvati F; Haider MA
    Eur Radiol; 2020 Dec; 30(12):6867-6876. PubMed ID: 32591889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically Significant Prostate Cancer Detection After a Negative Prebiopsy MRI Examination: Comparison of Biparametric Versus Multiparametric MRI.
    Gan JM; Kikano EG; Smith DA; Rao S; Podury R; Wang M; Durieux JC; Paspulati RM; Ponsky L; Ramaiya NH; Tirumani SH
    AJR Am J Roentgenol; 2022 May; 218(5):859-866. PubMed ID: 34817189
    [No Abstract]   [Full Text] [Related]  

  • 11. What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.
    Moldovan PC; Van den Broeck T; Sylvester R; Marconi L; Bellmunt J; van den Bergh RCN; Bolla M; Briers E; Cumberbatch MG; Fossati N; Gross T; Henry AM; Joniau S; van der Kwast TH; Matveev VB; van der Poel HG; De Santis M; Schoots IG; Wiegel T; Yuan CY; Cornford P; Mottet N; Lam TB; Rouvière O
    Eur Urol; 2017 Aug; 72(2):250-266. PubMed ID: 28336078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer detection with biparametric magnetic resonance imaging (bpMRI) by readers with different experience: performance and comparison with multiparametric (mpMRI).
    Gatti M; Faletti R; Calleris G; Giglio J; Berzovini C; Gentile F; Marra G; Misischi F; Molinaro L; Bergamasco L; Gontero P; Papotti M; Fonio P
    Abdom Radiol (NY); 2019 May; 44(5):1883-1893. PubMed ID: 30788558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prostate biopsy risk calculator based on MRI: development and comparison of the Prospective Loyola University multiparametric MRI (PLUM) and Prostate Biopsy Collaborative Group (PBCG) risk calculators.
    Patel HD; Koehne EL; Shea SM; Fang AM; Gerena M; Gorbonos A; Quek ML; Flanigan RC; Goldberg A; Rais-Bahrami S; Gupta GN
    BJU Int; 2023 Feb; 131(2):227-235. PubMed ID: 35733400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head-to-head comparison of biparametric versus multiparametric MRI of the prostate before robot-assisted transperineal fusion prostate biopsy.
    Thaiss WM; Moser S; Hepp T; Kruck S; Rausch S; Scharpf M; Nikolaou K; Stenzl A; Bedke J; Kaufmann S
    World J Urol; 2022 Oct; 40(10):2431-2438. PubMed ID: 35922717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI combined with PSA density in detecting clinically significant prostate cancer in patients with PSA serum levels of 4∼10ng/mL: Biparametric versus multiparametric MRI.
    Han C; Liu S; Qin XB; Ma S; Zhu LN; Wang XY
    Diagn Interv Imaging; 2020 Apr; 101(4):235-244. PubMed ID: 32063483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 3D-2D Hybrid U-Net Convolutional Neural Network Approach to Prostate Organ Segmentation of Multiparametric MRI.
    Ushinsky A; Bardis M; Glavis-Bloom J; Uchio E; Chantaduly C; Nguyentat M; Chow D; Chang PD; Houshyar R
    AJR Am J Roentgenol; 2021 Jan; 216(1):111-116. PubMed ID: 32812797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convolutional Neural Networks for Automated Classification of Prostate Multiparametric Magnetic Resonance Imaging Based on Image Quality.
    Cipollari S; Guarrasi V; Pecoraro M; Bicchetti M; Messina E; Farina L; Paci P; Catalano C; Panebianco V
    J Magn Reson Imaging; 2022 Feb; 55(2):480-490. PubMed ID: 34374181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the efficacy of multi-flavored feature extraction with radiomics and deep features for prostate cancer grading on mpMRI.
    Khanfari H; Mehranfar S; Cheki M; Mohammadi Sadr M; Moniri S; Heydarheydari S; Rezaeijo SM
    BMC Med Imaging; 2023 Nov; 23(1):195. PubMed ID: 37993801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric MRI and auto-fixed volume of interest-based radiomics signature for clinically significant peripheral zone prostate cancer.
    Bleker J; Kwee TC; Dierckx RAJO; de Jong IJ; Huisman H; Yakar D
    Eur Radiol; 2020 Mar; 30(3):1313-1324. PubMed ID: 31776744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)-do we still need contrast media?
    Huebner NA; Korn S; Resch I; Grubmüller B; Gross T; Gale R; Kramer G; Poetsch N; Clauser P; Haitel A; Fajkovic H; Shariat SF; Baltzer PA
    Eur Radiol; 2021 Jun; 31(6):3754-3764. PubMed ID: 33263793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.